Category: Prescription Drugs
Baldwin co-leads 340B reform bill
by Sean Kirkby | Aug 13, 2026 | Prescription Drugs, Top Stories | 0 |
U.S. Sen. Tammy Baldwin, D-Wis., is co-leading an effort to change a program that provides discounted drugs to safety-net healthcare providers.
Sandoz reaches $400 million tentative settlement with Wisconsin, other states
by Sean Kirkby | Aug 5, 2026 | Prescription Drugs, Top Stories | 0 |
A generic drugmaker reached a $400 million tentative settlement with Wisconsin and other states to resolve allegations it engaged in anticompetitive behavior.
Wisconsin helps secure $29.6 million settlement with generic drugmaker
by Sean Kirkby | Jul 20, 2026 | Prescription Drugs, Top Stories | 0 |
Wisconsin, along with other states and territories, secured a $29.6 million settlement with a generic drugmaker to resolve allegations the company engaged in anti-competitive activity.
Wisconsin will see payout from CVS settlement over Medicaid overbilling allegations
by Sean Kirkby | Jun 16, 2026 | Prescription Drugs, Top Stories | 0 |
Wisconsin will see $124,510 from a settlement with CVS Pharmacy that resolves allegations the pharmacy chain overbilled Medicaid for insulin pens.
FDA will accelerate review of Usona’s drug application for psilocybin
by Sean Kirkby | Apr 28, 2026 | Prescription Drugs, Top Stories | 0 |
The Food and Drug Administration will fast track review of Fitchburg-based Usona Institute’s application for using psilocybin to treat severe depression.
State employee health plan will cover anti-obesity medications next year
by Sean Kirkby | Mar 16, 2026 | Insurance, Prescription Drugs, Top Stories | 0 |
The board for the state employee health plan on Friday approved coverage of anti-obesity medications with a $200 copay starting next year.
How are competition, consolidation and transparency affecting healthcare costs?
by Sean Kirkby | Mar 13, 2026 | Hospitals, Insurance, On The Record, Prescription Drugs, Top Stories | 0 |
Healthcare industry stakeholders talked about how competition, consolidation and transparency are affecting healthcare costs during a Wisconsin Health News event Tuesday in Madison.
Read MorePanel dives into what to do about healthcare costs
by Sean Kirkby | Mar 11, 2026 | Hospitals, Insurance, Prescription Drugs, Top Stories | 0 |
Supporting access to preventive care, addressing the social determinants of health and taking steps to curb high drug prices could help bend the healthcare cost curve, healthcare industry stakeholders said at a Wisconsin Health News panel Tuesday. Meanwhile, a patient advocate called for larger-scale public policies.
Read MoreMoses: Assembly health committee ‘unlikely’ to vote on PBM bill
by Sean Kirkby | Feb 12, 2026 | Legislature, Prescription Drugs, Top Stories | 0 |
The Assembly’s health committee is “highly unlikely” to vote on advancing a sweeping pharmacy benefit manager reform bill this session, the committee chair said Wednesday.
State could provide $100 million in tax credits to support Eli Lilly expansion
by Sean Kirkby | Aug 6, 2025 | Prescription Drugs, Top Stories | 0 |
Gov. Tony Evers’ administration said Tuesday that the state could provide up to $100 million in tax credits to support Eli Lilly and Company’s growth in southeast Wisconsin, contingent on the drugmaker meeting job creation and capital investment targets.
Read MoreWisconsin to see money through Gilead agreement
by Sean Kirkby | Jul 29, 2025 | Prescription Drugs, Top Stories | 0 |
Wisconsin is expected to receive about $152,000 through a multistate settlement with Gilead Sciences to resolve allegations the company ran an illegal kickback scheme to promote its HIV medications.